Sr. Director, Total Rewards jobs in United States
cer-icon
Apply on Employer Site
company-logo

BridgeBio · 4 days ago

Sr. Director, Total Rewards

BridgeBio is a biotech company focused on developing life-changing medicines for patients with unmet needs. They are seeking a Senior Director, Total Rewards & Performance Management to set the vision and strategy for global compensation, benefits, and performance programs while leading a lean Total Rewards team.

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
check
Growth Opportunities

Responsibilities

Set the vision and multi-year strategy for BridgeBio’s Total Rewards and Performance Management programs, ensuring alignment with company goals, culture, and financial strategy
Personally lead the design and execution of annual compensation cycles, including merit, bonus, and equity programs
Own market benchmarking, job architecture, leveling frameworks, and pay structures across functions and geographies
Evolve BridgeBio’s performance management framework to ensure meaningful differentiation based on performance and impact
Partner closely with People Business Partners and leaders to drive effective goal-setting, performance assessment, and calibration
Define and execute a multi-year benefits strategy, including leading a transition to a self-funded medical model
Drive data, analytics, systems optimization, and process excellence across Total Rewards and Performance programs
Lead a small Total Rewards team by setting clear vision and priorities while remaining actively involved in execution
Partner with Finance, Legal, Talent Acquisition, and other People team members to ensure alignment, compliance, and effective delivery
Communicate Total Rewards and Performance strategies with clarity and transparency across the organization

Qualification

Total Rewards strategyCompensation programsPerformance management systemsBenefits strategyData analyticsLeadershipCommunicationCollaboration

Required

12+ years of progressive experience across Total Rewards, compensation, benefits, and/or performance management in a high-growth and/or global organization
Deep expertise in broad-based compensation and equity programs; experience partnering on executive compensation without direct ownership
Proven track record of designing and operating performance management systems that meaningfully link performance to rewards
Experience leading benefits strategy, including transitioning to a self-funded medical plan
Strong understanding of global pay practices, pay equity, and compliance considerations
Highly analytical with a strong execution bias and comfort operating as a hands-on leader
Ability to set clear strategy and direction while personally delivering results with a small, high-impact team

Benefits

401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities

Company

BridgeBio

twittertwittertwitter
company-logo
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Funding

Current Stage
Public Company
Total Funding
$4.35B
Key Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
2024-01-18Post Ipo Debt· $1.25B

Leadership Team

leader-logo
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
linkedin
leader-logo
Neil Kumar
CEO and Founder
linkedin
Company data provided by crunchbase